规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | NR4A1 is an orphan nuclear receptor which can activate mTOR signaling and exhibits pro-oncogenic activity in cancer cell lines, regulates genes such as thioredoxin domain containing 5 and isocitrate dehydrogenase 1 that maintain low oxidative stress, and coactivates specificity protein 1 (Sp1)-regulated pro-survival and growth promoting genes. DIM-C-pPhCO2Me is a NR4A1 antagonist. DIM-C-pPhCO2Me exhibited anti-proliferative effect on ACHN cells and 786-O cells with IC50 values of 11.7μM and 13.4μM, respectively, as well as induced apoptosis in both cell lines at concentration of 20μM post 24h. DIM-C-pPhCO2Me at concentration of 20μM inhibited NR4A1-regulated expression of survivin, bcl-2 and EGFR, decreased expression of TXNDC5 and IDH1, and induced stress shown by increased CHOP, ATF4 and p-PERK. Inhibition of NR4A1 by 20μM DIM-C-pPhCO2Me activated induced sestrin 2, activated AMPKα and inhibited activation of mTOR and downstream kinases including phosphorylation of p70S6K, S6RP and 4EBP1. Treatment with DIM-C-pPhCO2Me at concentration of 15μM or 20μM for 12h induced ROS production in Rh30 and RD cells. |
作用机制 | DIM-C-pPhCO2Me decreased interactions of NR4A1, p300 and pol II with the GC-rich TXNDC5 and IDH1 promoters and resulted in some loss of Sp1 from the TXNDC5 promoter.[2] |
Concentration | Treated Time | Description | References | |
786-O cells | 0–20μM | 24 hours | Inhibited cell proliferation and induced apoptosis | PLoS One. 2015 Jun 2;10(6):e0128308 |
ACHN cells | 0–20μM | 24 hours | Inhibited cell proliferation and induced apoptosis | PLoS One. 2015 Jun 2;10(6):e0128308 |
MCF-7 cells | 20 μM | 24 hours | To investigate the effect of DIM-C-pPhCO2Me on MCF-7 cell migration, results showed that the compound significantly inhibited cell migration. | Mol Cell Biol. 2016 Apr 15;36(9):1383-94 |
MDA-MB-231 cells | 20 μM | 24 hours | To investigate the effect of DIM-C-pPhCO2Me on MDA-MB-231 cell migration, results showed that the compound significantly inhibited cell migration. | Mol Cell Biol. 2016 Apr 15;36(9):1383-94 |
SKBR3 cells | 20 μM | 24 hours | To investigate the effect of DIM-C-pPhCO2Me on SKBR3 cell migration, results showed that the compound significantly inhibited cell migration. | Mol Cell Biol. 2016 Apr 15;36(9):1383-94 |
SW480 cells | 15 and 20 μM | 24 hours | Decreased β1-integrin expression, inhibited cell migration and adhesion | Mol Carcinog. 2017 Sep;56(9):2066-2075 |
RKO cells | 15 and 20 μM | 24 hours | Decreased β1-integrin expression, inhibited cell migration and adhesion | Mol Carcinog. 2017 Sep;56(9):2066-2075 |
MiaPaCa2 cells | 15 and 20 μM | 24 hours | Decreased β1-integrin expression, inhibited cell migration and adhesion | Mol Carcinog. 2017 Sep;56(9):2066-2075 |
L3.6pL cells | 15 and 20 μM | 24 hours | Decreased β1-integrin expression, inhibited cell migration and adhesion | Mol Carcinog. 2017 Sep;56(9):2066-2075 |
Panc1 cells | 15 and 20 μM | 24 hours | Decreased β1-integrin expression, inhibited cell migration and adhesion | Mol Carcinog. 2017 Sep;56(9):2066-2075 |
RD cells | 15 μM | 24 to 72 hours | To investigate the inhibitory effect of DIM-C-pPhCO2Me on the proliferation of RD cells, results showed that prolonged exposure time enhanced the inhibitory effect. | Oncotarget. 2016 May 24;7(21):31257-69 |
Rh30 cells | 5 to 15 μM | 24 hours | To investigate the inhibitory effect of DIM-C-pPhCO2Me on the proliferation of Rh30 cells, results showed that the compound effectively inhibited cell proliferation. | Oncotarget. 2016 May 24;7(21):31257-69 |
Administration | Dosage | Frequency | Description | References | ||
NSG mice | Breast cancer xenograft model | Oral gavage | 20 or 40 mg/kg/day | Every other day for 50 days | To evaluate the inhibitory effect of NR4A1 antagonist on tumor growth, results showed NR4A1-i caused tumor shrinkage, accompanied by increased FOS expression, elevated DNA damage marker γH2AX, and reduced Ki-67 expression | Mol Cell. 2021 Oct 7;81(19):4041-4058. e15 |
BALB/c nude mice | MDA-MB-231 xenograft model | 40 mg/kg/day | Daily administration, duration | To investigate the effect of DIM-C-pPhCO2Me on MDA-MB-231 xenograft tumors, results showed that the compound significantly inhibited tumor growth. | Mol Cell Biol. 2016 Apr 15;36(9):1383-94 | |
Athymic nude mice | ACHN cell xenograft model | Oral gavage | 30 mg/kg/day | Once daily for 50 days | Inhibited tumor growth | PLoS One. 2015 Jun 2;10(6):e0128308 |
Nude mice | Rh30 xenograft model | Oral gavage | 40 mg/kg/d | Every second day for 20 days | To investigate the inhibitory effect of DIM-C-pPhCO2Me on the growth of Rh30 xenograft tumors, results showed that the compound significantly inhibited tumor growth. | Oncotarget. 2016 May 24;7(21):31257-69 |
Dose | Nude Mice: 30 mg/kg[1] (p.o.) |
Administration | p.o. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.14mL 2.63mL 1.31mL |
26.29mL 5.26mL 2.63mL |
CAS号 | 151358-48-4 |
分子式 | C25H20N2O2 |
分子量 | 380.44 |
SMILES Code | O=C(OC)C1=CC=C(C(C2=CNC3=C2C=CC=C3)C4=CNC5=C4C=CC=C5)C=C1 |
MDL No. | MFCD31697720 |
别名 | |
运输 | 蓝冰 |
InChI Key | BBAOKSZCULLDIW-UHFFFAOYSA-N |
Pubchem ID | 15637614 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
溶解方案 |
DMSO: 120 mg/mL(315.42 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|